Other News

orkambi for cystic fibrosis
Sleep Disorders

FDA Approves ORKAMBI®, First Medicine to Treat the Underlying Cause of CF for Children Ages 2-5 Years with Most Common Form of the Disease

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]

man on exercise bike copd
Respiratory

Cannabis Does Not Improve Breathlessness During Exercise in Patients With Advanced COPD

Inhaled vaporized cannabis does not appear to improve or worsen exercise performance and activity-related breathlessness in patients with advanced chronic obstructive pulmonary disease (COPD), according to a randomized controlled trial published online in the Annals of the American Thoracic Society. In “Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise […]

Product News

SleepScore Mobile App Now Available to Android Users

Free app grants users worldwide access to their own scientifically validated SleepScore SleepScore, the definitive consumer standard of sleep measurement and improvement, today announced that its SleepScore mobile app – which turns mobile devices into a convenient, non-contact standalone sleep improvement system – is now available for free download on […]

Product News

BRAEBON BridgeBuilder Cloud Portal Upgrade Notice

The BRAEBON BridgeBuilder Cloud Portal will be upgraded on Tuesday, July 31st at 5 p.m. Eastern Time. Upgrades will include security and feature enhancements, including the roll-out of the all-new telemedicine capability which will be initially available to select users and later available to all users for a fee. More […]

Respiratory

Tobacco Regulation Advocates Get Support from Medical Professional Organizations in Court Filing

The American Thoracic Society led 10 medical professional organizations in filing an amicus brief last week regarding the FDA’s failure to apply pre-market review to new tobacco products. The brief was submitted in support of the American Academy of Pediatrics and its co-plaintiffs and outlines the compelling data indicating that the FDA’s failure to act […]

Research & Studies

Supplemental Oxygen Eliminates Morning Blood Pressure Rise in OSA Patients Following CPAP Withdrawal

Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea (OSA) patients who stop using continuous positive airway pressure (CPAP), the standard treatment for OSA, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Effect […]